In CRC, STAT3 affects T cell activity by inhibiting the function of antigen-presenting cells, and when STAT3 expression is inhibited, the tumor cells’ ability to evade the immune system is weakened, allowing the immune system to more effectively recognize and eliminate cancer cells (96). The gene discussed is STAT3; the disease is neoplasm.